Individuals who experienced sudden vision loss after taking semaglutide medications may benefit from having their case reviewed to determine whether they may qualify for the ongoing GLP-1 vision loss litigation
Semaglutide, in particular, has demonstrated a reduction in major cardiovascular events in clinical trials
& O'Meara, R
10.1152/japplphysiol.00876.2020 49 ShamshoumH.MedakK
Choose a high-quality whey protein isolate
WEIGHT TRACKING Weight log with progress charts Goal prediction based on current rate Support for kg and lbs Automatic BMI with WHO classification MEDICATION MANAGEMENT Dose log with injection site tracking Smart reminders for next dose Complete treatment history Treatment pause periods (surgery, medical advice, supply issues) HYDRATION Daily water intake with customizable goal Weekly and monthly statistics Hydration reminders EXERCISE & ACTIVITY Exercise log with type, duration and calories Automatic correlation with weight loss MEALS Meal log with photos AI-assisted nutritional analysis (Claude) SMART DASHBOARD Daily summary with personalised alerts and insights Trend analysis and predictions Treatment adherence with pause days excluded Consistency streaks protected during pauses PROGRESS PHOTOS Side-by-side comparison (before and after) Organisation by position and date BODY COMPOSITION Waist circumference, body fat, lean mass Visceral fat with risk scale Detailed progress charts MEDICAL REPORTS Full PDF report to share with your doctor SF-36 quality of life questionnaire CSV and Excel export NEW IN v3.0 Redesigned interface with 4 focused tabs Quick-register FAB log anything in 2 taps Settings reorganised into dedicated sections Configurable daily water goal Evolution hub with all progress in one place MULTILINGUAL Available in Portuguese, Brazilian Portuguese, English, Spanish, French and German
